Randomised clinical trial: The efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - A double-blind, placebo-controlled study

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 5, 2012, Pages 426-436

  Thorat, V ^a   Reddy, N ^b   Bhatia, S ^c   Bapaye, A ^d   Rajkumar, J S ^e   Kini, D D ^f   Kalla, M M ^g   Ramesh, H ^h  

^a Poona Hospital and Research Centre ^*  (India)

^b ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

^c KEM HOSPITAL   (India)

^d DEENANATH MANGESHKAR HOSPITAL   (India)

^e Lifeline Multispeciality Hospital   (India)

^f MANIPAL HOSPITAL   (India)

^g S R Kalla Memorial Hospital   (India)

^h Lakeshore Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREON 40000 MMS; FAT; NITROGEN; PANCRELIPASE; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; CHRONIC PANCREATITIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FECES ANALYSIS; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; HUMAN; HYPERCHLORHYDRIA; INDIA; LIPID ABSORPTION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NITROGEN DEPOSITION; PANCREAS EXOCRINE INSUFFICIENCY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INDIA; INTESTINAL ABSORPTION; MALE; MICROSPHERES; MIDDLE AGED; PANCREATITIS, CHRONIC; PANCRELIPASE; TREATMENT OUTCOME;

EID: 84864646589     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05202.x     Document Type: Article

References (27)

1. Etemad B, Whitcomb DC,. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707.
2. Nair RJ, Lawler L, Miller MR,. Chronic pancreatitis. Am Fam Physician 2007; 76: 1679-88.
3. Braganza JM, Lee SH, McCloy RF, McMahon MJ,. Chronic pancreatitis. Lancet 2011; 377: 1184-97.
4. Coté GA, Yadav D, Slivka A, et al,. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2011; 9: 266-73.
5. Balakrishnan V, Unnikrishnan AG, Thomas V, et al,. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 2008; 9: 593-600.
6. Tandon RK, Sato N, Garg PK,. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol 2002; 17: 508-18.
7. Barman KK, Premalatha G, Mohan V,. Tropical chronic pancreatitis. Postgrad Med J 2003; 79: 606-15.
8. Balakrishnan V, Nair P, Radhakrishnan L, Narayanan VA,. Tropical pancreatitis-a distinct entity, or merely a type of chronic pancreatitis? Indian J Gastroenterol 2006; 25: 74-81.
9. Mahurkar S, Reddy DN, Rao GV, Chandak GR,. Genetic mechanisms underlying the pathogenesis of tropical calcific pancreatitis. World J Gastroenterol 2009; 15: 264-9.
10. Domínguez-Muñoz JE,. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9: 116-22.
11. Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP,. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481-7.
12. Bhasin DK, Singh G, Rana SS, et al,. Clinical profile of idiopathic chronic pancreatitis in North India. Clin Gastroenterol Hepatol 2009; 7: 594-9.
13. Whitcomb DC, Lehman GA, Vasileva G, et al,. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol 2010; 105: 2276-86. Erratum in Am J Gastroenterol 2011; 106: 1177-8.
14. Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP,. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 156-62.
15. Mohan V, Poongothai S, Pitchumoni CS,. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int J Pancreatol 1998; 24: 19-22.
16. ® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros 2009; 8: 370-7.
17. Graff GR, Maguiness K, McNamara J, et al,. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Clin Ther 2010; 32: 89-103.
18. ®) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Clin Drug Investig 2010; 30: 351-64.
19. Stern RC, Eisenberg JD, Wagener JS, et al,. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000; 95: 1932-8.
20. Munck A, Duhamel JF, Lamireau T, et al,. Pancreatic enzyme replacement therapy for young cystic fibrosis patients. J Cyst Fibros 2009; 8: 14-8.
21. Colombo C, Fredella C, Russo MC, et al,. Efficacy and tolerability of Creon for children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Pancreas 2009; 38: 693-9.
22. Littlewood JM, Connett GJ, Sander-Struckmeier S, Henniges F,. A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis. Expert Opin Drug Saf 2011; 10: 197-203.
23. Van De Kamer JH, Ten Bokkel Huinink H, Weyers HA,. Rapid method for the determination of fat in feces. J Biol Chem 1949; 177: 347-55.
24. Gubergrits N, Malecka-Panas E, Lehman GA, et al,. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther 2011; 33: 1152-61.
25. Toskes PP, Secci A, Thieroff-Ekerdt R,. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis. Pancreas 2011; 40: 376-82.
26. Abdel Aziz AM, Lehman GA,. Current treatment options for chronic pancreatitis. Curr Treat Options Gastroenterol 2007; 10: 355-68.
27. Layer P, Keller J, Lankisch PG,. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001; 3: 101-8.